Register of patients with atrial fibrillation treated by cardiac surgery
CArdioSurgEry Atrial Fibrillation Register - CASE-AF Register
This study looks at how well different heart surgeries work for people with atrial fibrillation and what happens to them afterwards.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Stiftung Institut fuer Herzinfarktforschung Academic / other |
| Locations | 3 sites (München, Bavaria and 2 other locations) |
| Trial ID | NCT03091452 on ClinicalTrials.gov |
What this trial studies
CASE AF aims to document the medical care of patients undergoing cardiac surgical ablation for atrial fibrillation. The study will explore various indications for the procedure, the frequency and types of surgical interventions performed, and the safety and effectiveness of these treatments. It will also assess the long-term outcomes, including the recurrence of atrial fibrillation and the medical treatments provided post-surgery. This observational study will gather data from multiple centers to provide a comprehensive overview of current practices.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with atrial fibrillation who are undergoing cardiac surgical ablation.
Not a fit: Patients who are not undergoing cardiac surgical ablation or who decline participation in the study may not benefit from this research.
Why it matters
Potential benefit: If successful, this study could improve the understanding of cardiac surgical ablation outcomes, leading to better patient care and treatment strategies for atrial fibrillation.
How similar studies have performed: Other studies have explored surgical interventions for atrial fibrillation, but this specific observational approach to documenting care practices is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Atrial fibrilation * Treated by cardiac surgical ablation Exclusion Criteria: * Patient denies participation
Where this trial is running
München, Bavaria and 2 other locations
- Klinikum Bogenhausen — München, Bavaria, Germany (Recruiting)
- Asklepios Harburg — Hamburg, Free and Hanseatic City of Hamburg, Germany (Not_yet_recruiting)
- Schüchtermann Kliniken — Bad Rothenfelde, North Rhine-Westphalia, Germany (Recruiting)
Study contacts
- Principal investigator: Thorsten Hanke, MD — Asklepios Hamburg Harburg
- Study coordinator: Belgin Özdemir
- Email: oezdemir@stiftung-ihf.de
- Phone: 00496215032888
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.